Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in Working CapitalDeferred TaxesDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Transalta (TACPF) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Transalta (TACPF) over the last 17 years, with Q3 2025 value amounting to -$38.5 million.

  • Transalta's Capital Expenditures rose 2902.31% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $252.3 million, marking a year-over-year decrease of 7389.28%. This contributed to the annual value of $227.2 million for FY2024, which is 6497.35% down from last year.
  • As of Q3 2025, Transalta's Capital Expenditures stood at -$38.5 million, which was up 2902.31% from -$52.7 million recorded in Q2 2025.
  • In the past 5 years, Transalta's Capital Expenditures ranged from a high of $1.1 billion in Q4 2023 and a low of -$214.7 million during Q3 2022
  • Moreover, its 5-year median value for Capital Expenditures was -$54.2 million (2024), whereas its average is $93.6 million.
  • In the last 5 years, Transalta's Capital Expenditures tumbled by 26957.35% in 2023 and then surged by 7597.81% in 2024.
  • Over the past 5 years, Transalta's Capital Expenditures (Quarter) stood at $653.7 million in 2021, then surged by 57.66% to $1.0 billion in 2022, then increased by 8.04% to $1.1 billion in 2023, then plummeted by 67.15% to $365.8 million in 2024, then plummeted by 110.53% to -$38.5 million in 2025.
  • Its Capital Expenditures stands at -$38.5 million for Q3 2025, versus -$52.7 million for Q2 2025 and -$22.3 million for Q1 2025.